Home Page > ANTIBODY > POLYCLONAL ANTIBODY > Goat Polyclonal Antibodies >  Goat anti-AIBZIP / CREB3L4 Antibody

Goat anti-AIBZIP / CREB3L4 Antibody
Item#:
dAP-0336
Size Price Quantity
50.0 ug $310.00
Goat anti-AIBZIP / CREB3L4 Antibody
Principle Name AIBZIP / CREB3L4
Official Symbol CREB3L4
All Name and Symbols AIBZIP; cAMP responsive element binding protein 3-like 4, JAL, hJAL, ATCE1, CREB3, CREB4, androgen-induced basic leucine zipper; RP11-422P24.8; OTTHUMP00000035266; cAMP responsive element binding protein 1
Accession Number(s) NP_570968.1; NP_001242909.1
Peptide Sequence PSGRIRSVLHADEM, is from C Terminus
Human Gene ID(s) 148327
Non-Human GeneID(s)
Important Comments This antibody is expected to recognize both reported isoforms (NP_570968.1; NP_001242909.1). Reported variants represent identical protein
Purification Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Supplied As lyophilized powder of 50ug or 100ug IgG; Reconsititute IgG with 100ul or 200ul sterile DI Water and final product will be formulated as 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.
Applications Pep ELISA, WB, IHC
Tested Species Human
Peptide ELISA antibody detection limit dilution 1 to 32000.
Western Blot Approx 50kDa band observed in Human Placenta lysate (calculated MW of 43.4kDa according to NP_570968.1). The observed molecular weight corresponds to the glycosylated form. Recommended for use at 0.5-2µg/ml.
Immunohistochemistry In paraffin embedded Human Prostate shows strong staining of cytoplasm in the secretory cells of the gland. Recommended concentration, 2-4µg/ml.
Reference(s) Qi H, Fillion C, Labrie Y, Grenier J, Fournier A, Berger L, El-Alfy M, Labrie C. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells. Cancer Res. 2002 Feb 1;62(3)

ANGIO-PROTEOMIE, ALL RIGHTS RESERVED